Financial Enhancement Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.74M Sell
2,190
-12
-0.5% -$9.52K 0.25% 73
2025
Q1
$1.82M Buy
2,202
+74
+3% +$61.2K 0.28% 66
2024
Q4
$1.7M Buy
2,128
+266
+14% +$212K 0.26% 65
2024
Q3
$813K Sell
1,862
-447
-19% -$195K 0.16% 85
2024
Q2
$1.92M Buy
2,309
+438
+23% +$365K 0.31% 60
2024
Q1
$1.41M Buy
1,871
+9
+0.5% +$6.77K 0.23% 73
2023
Q4
$1.17M Hold
1,862
0.21% 70
2023
Q3
$1.15M Hold
1,862
0.22% 72
2023
Q2
$846K Hold
1,862
0.16% 82
2023
Q1
$813K Buy
1,862
+36
+2% +$15.7K 0.16% 85
2022
Q4
$622K Sell
1,826
-125
-6% -$42.6K 0.12% 92
2022
Q3
$631K Hold
1,951
0.15% 75
2022
Q2
$633K Hold
1,951
0.14% 71
2022
Q1
$559K Sell
1,951
-420
-18% -$120K 0.1% 76
2021
Q4
$655K Buy
2,371
+54
+2% +$14.9K 0.12% 73
2021
Q3
$535K Sell
2,317
-97
-4% -$22.4K 0.1% 72
2021
Q2
$554K Hold
2,414
0.11% 66
2021
Q1
$451K Buy
2,414
+179
+8% +$33.4K 0.09% 70
2020
Q4
$377K Buy
2,235
+365
+20% +$61.6K 0.08% 84
2020
Q3
$277K Buy
1,870
+35
+2% +$5.18K 0.06% 84
2020
Q2
$301K Buy
1,835
+370
+25% +$60.7K 0.08% 84
2020
Q1
$203K Hold
1,465
0.06% 89
2019
Q4
$193K Hold
1,465
0.05% 80
2019
Q3
$164K Buy
1,465
+125
+9% +$14K 0.04% 80
2019
Q2
$148K Hold
1,340
0.04% 94
2019
Q1
$174K Hold
1,340
0.05% 92
2018
Q4
$144K Hold
1,340
0.05% 94
2018
Q3
$144K Hold
1,340
0.05% 94
2018
Q2
$114K Sell
1,340
-213
-14% -$18.1K 0.04% 95
2018
Q1
$120K Buy
+1,553
New +$120K 0.04% 98